Pulmonary hypertension (PH) is a heterogeneous group of disorders that can be classified
according to clinical, hemodynamic and pathological findings and the prognosis of
each group differs substantially [
[1]
]. Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension
(CTEPH) are distinct types of pre-capillary PH, defined by mean pulmonary arterial
pressure (mPAP) >20 mmHg, pulmonary arterial wedge pressure (PAWP) ≤15 mmHg and PVR ≥ 3
Wood units [
[2]
].- Simonneau G.
- Montani D.
- Celermajer D.S.
- Denton C.P.
- Gatzoulis M.A.
- Krowka M.
- et al.
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Eur Respir J. 2019 Jan 24; 53 (pii: 1801913)https://doi.org/10.1183/13993003.01913-2018
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.Eur Heart J. 2016; 37 (The Oxford University Press): 67-119
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension.Eur Respir J. 2019 Jan 24; 53 (pii: 1801913)https://doi.org/10.1183/13993003.01913-2018
- Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018.Int J Cardiol. 2018 Dec 1; 272S: 69-78https://doi.org/10.1016/j.ijcard.2018.08.079
- A global view of pulmonary hypertension.Lancet Respir Med. 2016; 4 (Apr): 306-322https://doi.org/10.1016/S2213-2600(15)00543-3
- An epidemiological study of pulmonary arterial hypertension.Eur Respir J. 2007; 30: 104-109https://doi.org/10.1183/09031936.00092306
- Pulmonary arterial hypertension in France: results from a national registry.Am J Respir Crit Care Med. 2006; 173: 1023-1030https://doi.org/10.1164/rccm.200510-1668OC
- Survival in pulmonary hypertension in Spain: insights from the Spanish registry.Eur Respir J. 2012; 40: 596-603https://doi.org/10.1183/09031936.00101211
- Growing number of incident pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in Latvia: a shifting epidemiological landscape? Data from a national pulmonary hypertension registry.Eur J Intern Med. 2019; 59 (Jan): e16-e17https://doi.org/10.1016/j.ejim.2018.09.017
- Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe.Pulm Circ. 2018; 8 (Jul-Sep)https://doi.org/10.1177/2045894018780521
- The need for national registries in rare diseases.Am J Respir Crit Care Med. 2006; 174: 228a-229https://doi.org/10.1164/ajrccm.174.2.228a
Article info
Publication history
Published online: May 14, 2019
Accepted:
April 30,
2019
Received:
April 29,
2019
Identification
Copyright
© 2019 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
